In a small study, sublingual immunotherapy (SLIT) was effective in desensitizing peanut-allergic toddlers, allowing 74 percent to consume 4,443 milligrams… Read more »
BY ALLERGIC LIVING When the U.S. Food and Drug Administration (FDA) approved a new oral immunotherapy (OIT) for peanut allergy… Read more »
Phase 3 results from the European clinical trial of the Palforzia peanut OIT treatment show that desensitization to the allergenic… Read more »
Allergist Dr. Michael Manning explains how oral immunotherapy (OIT) for food allergy works and shares his experience working with families to ease anxiety.
Desensitizing therapies are emerging for food allergies, and being considered for approval by the FDA. But some in the medical… Read more »
The manufacturer of the Viaskin Peanut patch has resubmitted its biologics license application (or BLA) to the FDA – in… Read more »
They’re the courageous food allergy parents and children testing therapies still in the experimental stages.
Allergies to peanut are one of the most common and severe types of food allergies.